key: cord-0717633-x256nbnc
authors: Barata Kasal, Daniel Arthur; De Lorenzo, Andrea; Tibiriçá, Eduardo
title: COVID-19 and Microvascular Disease: Pathophysiology of SARS-Cov-2 Infection With Focus on the Renin-Angiotensin System
date: 2020-09-02
journal: Heart Lung Circ
DOI: 10.1016/j.hlc.2020.08.010
sha: 03ec47cfeae7d25e48da358fc67b1d7ca910ef6a
doc_id: 717633
cord_uid: x256nbnc

The recently described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people, with thousands of fatalities. It has prompted global efforts in research, with focus on the pathophysiology of coronavirus disease-19 (COVID-19), and a rapid surge of publications. COVID-19 has been associated with a myriad of clinical manifestations, including the lungs, heart, kidneys, central nervous system, gastrointestinal system, skin, and blood coagulation abnormalities. The endothelium plays a key role in organ dysfunction associated with severe infection, and current data suggest that it is also involved in SARS-CoV-2-induced sepsis. This critical review aimed to address a possible unifying mechanism underlying the diverse complications of COVID-19: microvascular dysfunction, with emphasis on the renin-angiotensin system. In addition, research perspectives are suggested in order to expand understanding of the pathophysiology of the infection.

Seven months after the first case descriptions of the coronavirus disease 19 and the identification of the causal agent [1] , the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been diagnosed in almost 15,000,000 people and claimed >617,000 lives (accessed 22 July 2020 https://coronavirus.jhu.edu/map.html). Global efforts in research, including the pathophysiology of COVID-19, have been undertaken, with a rapid and rarely seen surge of publications related to a single disease, within months [2] . Accordingly, COVID-19 has been associated with a myriad of clinical manifestations, including the lungs [3] , heart [4] , kidneys [5] , central nervous system [6] , gastrointestinal system [7] , skin [8] , and blood coagulation abnormalities [9] .

During infection, the endothelium displays an essential role in the physiological adaptive processes, adjusting blood flow to regions of increased metabolic demand and enabling the access of immune defence cells to the site of infection [10] . When activated by sepsis, dysfunctional endothelium can lead to intravascular thrombosis, amplification of the inflammatory process and disturbances in regional blood flow [11] .

J o u r n a l P r e -p r o o f As a consequence, endothelial dysfunction is considered the main factor leading to organ failure in sepsis [12] . Understanding the molecular pathways involved in vascular pathophysiology during sepsis is a key step towards the development of therapy strategies.

The renin-angiotensin system (RAS) is essential for vascular homeostasis, with actions ranging from plasma volume regulation to vascular tone and inflammation [13, 14] . In severe bacterial sepsis, previous studies have demonstrated RAS activation [15, 16] . Severe COVID-19 has been viewed as viral sepsis, followed by exuberant cytokine production [17] , and also associated with RAS imbalance.

The present review aimed to address microvascular dysfunction as a possible unifying mechanism underlying the diverse manifestations of COVID-19, with emphasis on the interactions with RAS.

Microcirculation is well recognised as a component of the response to pathogens, which can be either adaptive or dysfunctional. The physiological microvascular response that occurs in mild to moderate infection characterises most of the classical signs of inflammation (Latin, calor, dolor, rubor, tumor) and is a direct result of cytokine-driven vasodilation at the site of pathogen inoculation [18] . Contrary to this are the extensive abnormalities of endothelial function, which may occur in sepsis, associated with disseminated intravascular coagulation (DIC) [19] and a heterogeneous vasomotor response, where hypotension and shock are associated with microvascular vasoconstriction [20] . Previous evidence of microvascular dysfunction associated with acute viral infection was provided during the influenza A (H1N1) pandemic. Salgado et al. evaluated microcirculation in critical patients with acute lung injury [21] . The degree of microvascular dysfunction correlated with the severity of the disease, as measured by the Sequential Organ Failure Assessment (SOFA) score.

The effects of inflammation on endothelial cells include increased expression of adhesion molecules, stimulated by proinflammatory cytokines and chemokines such as IL-1β and TNF-α, and C-reactive protein, that is produced in response to IL-6, amongst others [22, 23] . Thrombotic phenomena, reflecting a close relationship between increased proinflammatory cytokines, may ensue endothelial dysfunction and vascular J o u r n a l P r e -p r o o f thrombosis. Patients with severe COVID-19 have displayed the 'cytokine storm' [24] , in which proinflammatory cytokines are increased, culminating in multiorgan injury.

This has been hypothesised as an exaggerated host immune system response, similar to the findings of other severe viral pneumonias such as influenza, avian influenza, and severe acute respiratory syndrome [25, 26] . The vicious cycle involving cytokine overproduction and microvascular endothelial injury appears to be an essential factor leading patients with severe COVID-19 to multiple organ failure and even death [27, 28] . Thus, therapeutic interventions to mitigate inflammatory organ injury have been proposed, and the beneficial role of corticosteroids for patients with COVID-19

who required respiratory support has recently been shown in the RECOVERY trial [29] .

Interestingly, another effect of corticosteroids, via mineralocorticoid receptor binding, has also been suggested in COVID-19, with possible interplay with RAS [30] .

Most current studies of COVID-19 are focused on the macrocirculation, evaluating systemic arterial pressure, the use of vasopressors, and systemic markers of impaired tissue perfusion such as lactate. As a consequence, the reported prevalence of septic shock in adults with a diagnosis of COVID-19 ranges between 20%-35%, according to the population studied, the severity of the patient sample and the definition of septic shock that is used [31, 32] .

Notwithstanding, mounting evidence suggests that microcirculation is a key player of SARS-CoV-2-induced pathophysiology. The angiotensin-converting enzyme type 2 (ACE2) is described as the receptor required for the viral particle cell entry [33] .

This process involves priming of the viral surface spike (S) protein by the host cell serine protease TMPRSS2, as a prerequisite for cell and viral membrane fusion [33] . In addition, viral S protein has been demonstrated to induce downregulation of ACE2 [34] .

These findings, together with the previous demonstration of ACE2 and TMPRSS2 expression in endothelial cells [35, 36] , along with other molecules involved in viral infection [37] , provide a pathophysiological mechanism to support the hypothesis of 

A second significant aspect of SARS-CoV-2-induced endothelial dysfunction is a procoagulant state. This phenomenon has important consequences on the pulmonary complications of COVID-19. Post-mortem examination of COVID-19 elderly, hypertensive, obese, and male patients has shown that impaired microcirculation was characterised by pulmonary capillary alterations and the presence of capillary microthrombi [40] .

The association between microvascular disease and hypercoagulability (expressed by increased D-dimer) has previously been recognised in patients with traditional cardiovascular risk factors, including diabetes [42, 43] . Additionally, hypercoagulability has been shown to accompany the progression of atherosclerosisassociated endothelial dysfunction [44] . Increased D-dimer levels are frequently found among patients with COVID-19, especially in those with severe disease, and are associated with worse prognosis, including increased risk of intensive care admission, mechanical ventilation and death [45] [46] [47] . For these reasons, D-dimer monitoring may be considered valuable in decision-making and patient care, as lower mortality has been J o u r n a l P r e -p r o o f reported in patients with increased D-dimer who were treated with heparin, compared with those who were not [48] . The proinflammatory actions of Ang II involve innate and adaptive immune responses [14] . Accordingly, mice chronically infused with Ang II display increased vascular oxidative stress and macrophage infiltration, cytokine production and endothelial dysfunction. All of these effects were prevented by an immunologic approach, by infusing the anti-inflammatory regulatory T lymphocytes (Tregs) [55] .

The RAS is an essential component of vascular homeostasis, where the key enzymes ACE and ACE2 display antagonistic actions. Ang II produced by ACE induces oxidative stress, cell proliferation and inflammation [56] . Conversely, Ang-(1-7), the end product of the enzymatic action of ACE2, is associated with antioxidant and antiinflammatory effects [57] .

RAS imbalance has previously been suggested in bacterial sepsis. Evaluating the plasma of septic patients, Boldt et al. found higher circulating levels of Ang II when compared with controls, which were suppressed with the administration of the ACE inhibitor enalaprilat [15] . These findings were expanded by Doerschug et al., who identified that increased Ang II and plasma rennin activity in septic subjects were associated with microvascular dysfunction [16] . Literature investigating the association between viral infection and RAS is scarce. Evaluating patients with chronic hepatitis C infection, Powell et al. found an association between hepatic fibrosis and one polymorphism in the angiotensinogen gene, which was related to increased Ang II synthesis [58] .

The modulation of RAS in sepsis has been evaluated as a potential therapy by different approaches in the last decade. In the study with enalaprilat mentioned above [15] with a small number of patients (n=40), there was no difference in survival rate compared with the control group. Akipnar et al. investigated the effects of the renin inhibitor aliskiren in bacterial sepsis-induced acute lung injury in rats [59] . The authors J o u r n a l P r e -p r o o f found a reduction in plasma Ang II, which was associated with a reduction of oxidative stress markers and cytokine expression in lung tissue, including IL-6 and TNF-α.

Similar results were obtained in rodents with reduced lung injury during sepsis, which was associated with plasma decrease of IL-6 and TNF- using the angiotensin receptor blockers (ARBs) losartan [60] and candesartan [61] . ACE2 has also been associated with the potential beneficial effects of pharmacological interventions in RAS.

Imai et al. showed that the administration of recombinant ACE2 reduced lung injury in mice during bacterial sepsis [62] . In addition, the administration of ACE inhibitors and ARBs increased the cardiac expression of ACE2 and plasma Ang-(1-7) in mice [63] .

Indirect clinical evidence of the potential benefits of RAS modulation in infection was provided by a meta-analysis of 37 studies, which evaluated the effects of ACE inhibitors and ARBs in the risk of pneumonia [64] . The authors found that ACE inhibitors reduced the risk of pneumonia and pneumonia-related mortality, a benefit that was extended to high-risk patients, including those with heart failure and stroke.

Evidence suggesting a coronavirus-induced imbalance between ACE and ACE2 actions was previously provided by Kuba et al., who demonstrated, in the airways of mice that had been exposed to the related virus SARS-CoV, that ACE2 downregulation was associated with a local increase of Ang II [34] . Clinical studies with COVID-19

patients have demonstrated that blood levels of TNF-α and IL-6 are increased and positively correlate with disease severity [65] . Both cytokines are associated with endothelial barrier breakdown in sepsis [66] and reduced by Ang-(1-7) [67] .

This working hypothesis of the vascular effects of SARS-CoV-2 is even more relevant in view of clinical evidence from cohorts in at least three continents identifying cardiovascular disease and particularly hypertension as important risk factors associated with worse prognosis of COVID-19 [68] [69] [70] . Indeed, in hypertensive patients, RAS was found to be imbalanced towards ACE activation [71] , with ACE and Ang II expressed in higher levels in vascular tissues of patients exposed to cardiovascular risk factors [72] . Figure 1 .

The interplay between RAS and the microcirculation in SARS-CoV-2 infection brings up the opportunity of exciting research perspectives. It is vital to understand the dynamics of microcirculatory function during the clinical evolution of COVID-19, with particular interest in the largely unknown initial oligosymptomatic stage. Early signs of endothelial dysfunction were previously identified in human microcirculation, days before the clinical diagnosis of bacterial disease [73] . Indeed, a timely therapeutic action in the early phase is a key principle of sepsis management [74] . As a consequence, microcirculation evaluation, which can be performed at the bedside with non-invasive methods [75] , may offer important clinical data regarding prognosis and treatment effects [76] .

Another important issue in current comprehension of COVID-19 is to further investigate preliminary reports of young patients without known risk factors presenting severe disease, with vascular manifestations including stroke [77] . A number of pathophysiological mechanisms are proposed regarding this complication and should be subject of future research. These include direct central nervous system endothelial infection [39] , cytokine-induced local microcirculatory dysfunction [78] , and the development of antiphospholipid antibodies [79] .

It was previously known that ACE polymorphisms are associated with vascular complications such as diabetic nephropathy [80] . Furthermore, combinations of polymorphisms of both ACE and ACE2 have been associated with the susceptibility of developing hypertension [81] . Another recent evidence was reported by Bunyavanich et al., who found an age-dependent expression of ACE2 in nasal epithelial cells of COVID-19 patients, with adults displaying higher levels than children [82] . To 

At present, the scientific community is beginning to understand the pathophysiology of COVID-19. The RAS is a powerful homeostatic system, developed in the evolutionary process during the past hundred million years, allowing salt and water retention essential for vertebrates once they left their original marine environment [83] , with diverse fundamental roles in health and disease. Traditionally studied in the context of chronic cardiovascular diseases, a renewed interest in RAS inflammatory and microvascular actions has been prompted by the COVID-19 pandemic. Understanding these mechanisms can lead to more effective treatments for control of this global pandemic.

A novel coronavirus from patients with pneumonia in China

The scientific literature on

COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review

Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China

COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease

Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): a meta-analysis

Neurologic manifestations of hospitalized patients with coronavirus disease

Gastrointestinal and liver manifestations in patients with COVID-19

Cutaneous manifestations in COVID-19: a first perspective

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up

Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease)

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

The endothelium in sepsis

Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research

Immune mechanisms in hypertension and vascular injury

Influence of angiotensinconverting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill

Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis

The pathogenesis and treatment of the `cytokine storm' in COVID-19

Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation

Systemic versus localized coagulation activation contributing to organ failure in critically ill patients

Role of connexins in microvascular dysfunction during inflammation

Microcirculatory abnormalities in patients with severe influenza A (H1N1) infection

The role of inflammatory cytokines in endothelial dysfunction

New markers of inflammation and endothelial cell activation: Part I

Cytokine release syndrome in severe COVID-19

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

SARS-CoV-2 and viral sepsis: observations and hypotheses

COVID-19 sepsis and microcirculation dysfunction

Dexamethasone in hospitalized patients with Covid-19 -preliminary report

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis

Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways

Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence

Endothelial cell infection and endotheliitis in COVID-19

Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2)

Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction

Microvascular alterations in patients with SARS-COV-2 severe pneumonia

D-dimer levels in type 1 and type 2 diabetic children and adolescents; Relation to microvascular complications and dyslipidemia "own data and review

Von Willebrand Factor, ADAMTS13 and D-Dimer are correlated with different levels of nephropathy in type 1 diabetes mellitus

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Severe COVID-19 infection associated with endothelial activation

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Angiotensin II, tissue factor and the thrombotic paradox of hypertension

T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury

Cardiac inflammation after ischemia-reperfusion of the kidney: role of the sympathetic nervous system and the renin-angiotensin system

The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin

Host genetic factors influence disease progression in chronic hepatitis C

What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsisinduced lung injury

Losartan prevents sepsisinduced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases

Low-dose candesartan improves renal blood flow and kidney oxygen tension in rats with endotoxin-induced acute kidney dysfunction

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis

COVID-19 cytokine storm: the interplay between inflammation and coagulation

Mind the gap: mechanisms regulating the endothelial barrier

Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages

Clinical characteristics of coronavirus disease 2019 in China

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Clinical characteristics of Covid-19 in New York City

Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats

A review of the role of bradykinin and nitric oxide in the cardioprotective action of angiotensinconverting enzyme inhibitors: focus on perindopril

Changes in microcirculation as early markers for infection in preterm infants--an observational prospective study

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Current methods to assess human cutaneous blood flow: an updated focus on laser-based-techniques

Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease

Large-vessel stroke as a presenting feature of COVID-19 in the young

Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights

Coagulopathy and antiphospholipid antibodies in patients with Covid-19

The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients

Nasal gene expression of angiotensinconverting enzyme 2 in children and adults

Emergence and evolution of the renin-angiotensin-aldosterone system

All above authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The authors declare that they have no competing interests. J o u r n a l P r e -p r o o f